loadpatents
Patent applications and USPTO patent grants for Huang; Hualiang.The latest application filed is for "gene engineering recombinant anti-cea, anti-cd3, and anti-cd28 single-chain tri-specific antibody".
Patent | Date |
---|---|
Gene Engineering Recombinant Anti-CEA, Anti-CD3, And Anti-CD28 Single-Chain Tri-Specific Antibody App 20090117108 - Wang; Xiangbin ;   et al. | 2009-05-07 |
Anti human ovarian cancer-anti CD3 bispecific antibody App 20080138339 - Huang; Hualiang ;   et al. | 2008-06-12 |
Anti human ovarian cancer-anti CD3 bispecific antibody Grant 7,262,276 - Huang , et al. August 28, 2 | 2007-08-28 |
Anti human ovarian cancer-anti cd3 bispecific antibody App 20050255115 - Huang, Hualiang ;   et al. | 2005-11-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.